Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Clinical Science (London, England : 1979)
|
August 28, 1999
Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis
D Pateron, F Oberti, P Lefilliatre, et al.
Journal of Hepatology
|
October 6, 2000
Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
J Heller, P Sogni, E Barrière, et al.
Scandinavian Journal of Gastroenterology
|
April 18, 2001
Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose
R Moreau, C Chagneau, J Heller, et al.
European Journal of Gastroenterology & Hepatology
|
April 11, 2001
Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis
I Colle, R Moreau, F Pessione, et al.
European Cytokine Network
|
July 29, 1998
Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin
V Bertrand, S Quéré, R Guimbaud, et al.
Hepatology (Baltimore, Md.)
|
March 3, 1999
Elevated circulating cardiac troponin I in patients with cirrhosis
D Pateron, P Beyne, T Laperche, et al.
Journal of Viral Hepatitis
|
October 7, 2017
Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)
S Nordmann, A Vilotitch, P Roux, et al.
Alimentary Pharmacology & Therapeutics
|
July 14, 2016
The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study
P Sultanik, L Kramer, D Soudan, et al.
Gastroenterologie Clinique Et Biologique
|
June 29, 1999
[Treatment of portal hypertension]
P Calès, D Castaing, J D Grangé, et al.
Alimentary Pharmacology & Therapeutics
|
July 29, 2008
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression
L Peyrin-Biroulet, J-F Cadranel, J-B Nousbaum, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Clinical Science (London, England : 1979)
|
August 28, 1999
Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis
D Pateron, F Oberti, P Lefilliatre, et al.
Journal of Hepatology
|
October 6, 2000
Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
J Heller, P Sogni, E Barrière, et al.
Scandinavian Journal of Gastroenterology
|
April 18, 2001
Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose
R Moreau, C Chagneau, J Heller, et al.
European Journal of Gastroenterology & Hepatology
|
April 11, 2001
Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis
I Colle, R Moreau, F Pessione, et al.
European Cytokine Network
|
July 29, 1998
Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin
V Bertrand, S Quéré, R Guimbaud, et al.
Hepatology (Baltimore, Md.)
|
March 3, 1999
Elevated circulating cardiac troponin I in patients with cirrhosis
D Pateron, P Beyne, T Laperche, et al.
Journal of Viral Hepatitis
|
October 7, 2017
Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)
S Nordmann, A Vilotitch, P Roux, et al.
Alimentary Pharmacology & Therapeutics
|
July 14, 2016
The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study
P Sultanik, L Kramer, D Soudan, et al.
Gastroenterologie Clinique Et Biologique
|
June 29, 1999
[Treatment of portal hypertension]
P Calès, D Castaing, J D Grangé, et al.
Alimentary Pharmacology & Therapeutics
|
July 29, 2008
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression
L Peyrin-Biroulet, J-F Cadranel, J-B Nousbaum, et al.
Page
of 10